HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Dipeptidyl-Peptidase IV Inhibitors

Compounds that suppress the degradation of INCRETINS by blocking the action of DIPEPTIDYL-PEPTIDASE IV. This helps to correct the defective INSULIN and GLUCAGON secretion characteristic of TYPE 2 DIABETES MELLITUS by stimulating insulin secretion and suppressing glucagon release.
Also Known As:
Dipeptidyl-Peptidase 4 Inhibitors; Dipeptidyl Peptidase 4 Inhibitors; Dipeptidyl Peptidase IV Inhibitors; Inhibitors, Dipeptidyl-Peptidase IV; Gliptins
Networked: 87 relevant articles (7 outcomes, 5 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Scheen, André J: 5 articles (04/2015 - 06/2012)
2. Scheen, A J: 2 articles (08/2015 - 04/2012)
3. Cahn, Avivit: 2 articles (08/2015 - 06/2013)
4. Kuritzky, Louis: 2 articles (10/2014 - 08/2010)
5. Kendall, David M: 2 articles (07/2009 - 06/2009)
6. Cuddihy, Robert M: 2 articles (07/2009 - 06/2009)
7. Bergenstal, Richard M: 2 articles (07/2009 - 06/2009)
8. Špinar, Jindřich: 1 article (11/2015)
9. Špinarová, Lenka: 1 article (11/2015)
10. Tziomalos, Konstantinos: 1 article (11/2015)

Related Diseases

1. Type 2 Diabetes Mellitus (MODY)
2. Hyperglycemia
3. Hypoglycemia (Reactive Hypoglycemia)
4. Diabetes Mellitus
5. Body Weight (Weight, Body)

Related Drugs and Biologics

1. Glucagon-Like Peptide 1 (GLP 1)
2. Incretins
3. Glucagon (Glukagon)
4. Glucose (Dextrose)
5. Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)
6. Insulin (Novolin)
7. Sodium
8. Carbon Monoxide
9. Metformin (Glucophage)
10. Hypoglycemic Agents (Hypoglycemics)

Related Therapies and Procedures

1. Subcutaneous Injections